Sinocelltech Ltd.

This study is testing whether adding a new drug called SCTC21C to a standard three-drug combination works better and is safe for people newly diagnosed with light-chain amyloidosis, a rare disease where abnormal proteins damage organs. It will involve 90 participants who will rec…

This study is testing the safety and effectiveness of a drug called SCT800 to prevent bleeding episodes in people with severe hemophilia A. It will involve 36 male patients who have never received standard clotting factor treatment before. The main goal is to see if the drug work…

This study is testing a new drug called SCT520FF, given as an injection into the eye, for people with 'wet' age-related macular degeneration (AMD). The main goals are to find a safe dose and see if it helps improve or stabilize vision. Researchers will enroll about 82 patients to…

This study aims to see if a new drug called SCTB14 works better than the standard drug pembrolizumab (Keytruda) for people with a specific type of advanced lung cancer. It will involve about 246 adults whose cancer has spread, has no specific genetic drivers, and has not been tre…

This study is testing whether adding a new drug called SCTC21C to a standard three-drug combination works better for controlling newly diagnosed multiple myeloma. It will involve about 292 patients who are not eligible for a stem cell transplant. The main goal is to see if the fo…